Cloud monitoring software company Datadog (NASDAQ:DDOG) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 25.1% year on year to $737.7 million. The company expects next quarter’s revenue to be around $739 million, close to analysts’ estimates. Its non-GAAP profit of $0.49 per share was 13.3% above analysts’ consensus estimates.
S&P Global completed the list of top credit rating agencies to warn that an "unprecedented" U.S. withdrawal from the World Bank and other top multilateral lenders would damage their prized triple-A credit ratings. President Donald Trump signed an Executive Order last week for a six-month review of U.S. support to all international intergovernmental organisations to decide whether it should withdraw from them, or seek their reform. S&P said the current triple-A ratings of the World Bank and other top development banks assume the U.S. remaining in place.
Fast-food chain Wendy’s (NASDAQ:WEN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.2% year on year to $574.3 million. Its non-GAAP profit of $0.25 per share was in line with analysts’ consensus estimates.
Footwear company Crocs (NASDAQ:CROX) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 3.1% year on year to $989.8 million. On the other hand, next quarter’s revenue guidance of $905.8 million was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $2.52 per share was 11.3% above analysts’ consensus estimates.
Energy and industrial distributor DistributionNOW (NYSE:DNOW) announced better-than-expected revenue in Q4 CY2024, with sales up 2.9% year on year to $571 million. Its non-GAAP profit of $0.25 per share was 92.3% above analysts’ consensus estimates.
Beauty supply retailer Sally Beauty (NYSE:SBH) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $937.9 million. On the other hand, next quarter’s revenue guidance of $899.3 million was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $0.43 per share was in line with analysts’ consensus estimates.
Beer company Molson Coors (NYSE:TAP) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 2% year on year to $2.74 billion. Its non-GAAP profit of $1.30 per share was 15.3% above analysts’ consensus estimates.
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.2% year on year to $5.32 billion. Its non-GAAP profit of $1.45 per share was 14.8% above analysts’ consensus estimates.
Agricultural and construction machinery company Deere (NYSE:DE) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 18.9% year on year to $8.51 billion. Its GAAP profit of $3.19 per share was 1.8% below analysts’ consensus estimates.
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue guidance of $2.89 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 5.3% above analysts’ consensus estimates.